Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

Combined Synopsis Solicitation-Integrated PET trac

Active
75N98026Q00629Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, is soliciting proposals for a firm fixed-price contract under solicitation number 75N98026Q00629. This combined synopsis/solicitation, issued in accordance with FAR Subpart 12.6 and FAR 12.603 for streamlined commercial acquisitions, serves as the sole solicitation for this competitive procurement. The acquisition seeks commercial products or services related to Integrated PET tracers, classified under NAICS code 334516, and is intended to be awarded based on best value to the government, using full and open competition. Proposals must be submitted by June 25, 2026, with the solicitation posted on June 15, 2026. The solicitation is not expected to exceed the simplified acquisition threshold. The contract will be awarded by the NIH Office of Acquisitions, located in Bethesda, Maryland. The primary point of contact for this procurement is John R. Johnson, who can be reached via the provided NIH email address. Interested parties can review the solicitation and submit proposals through the official government procurement portal.

General Info

NIH seeks proposals for firm fixed-price Integrated PET tracers contract; submissions due June 25, 2026.

Agency

Department Of Health And Human Services → National Institutes Of Health Olao

NAICS

334516 - Analytical Laboratory Instrument Manufacturing View NAICS

Place of Performance

MD

Set-Aside

NONE

Documents

(1)

RFQ 75N98026Q00629 for TRACERlab FX2 C

PDF•rfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseCombined Synopsis
Posted

Combined Synopsis

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Olao
Office AddressBETHESDA, MD, 20892, USA
Contacts
JOHNSON JOHN R
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.
(ii) The solicitation number is 75N98026Q00629/PCA-NIA-02475. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold (if applicable).
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a firm fiex-price contract to the responsible offeror whose proposal represents the best value to the Government.

Similar Contracts

NAICS: 334516
New
Federal
NOI - PCA-NHLBI-07088The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, is issuing a non-competitive combined synopsis/solicitation under solicitation number 75N98026Q00630 to procure two complete CD Leycom INCA Pressure-Volume Loop Systems along with associated accessories, disposable catheters, and platinum-level training and support. This procurement supports clinical studies conducted by the National Heart, Lung, and Blood Institute’s Laboratory of Cardiovascular Intervention under an Investigational Device Exemption. The purchase will be awarded as a firm-fixed-price order to CD Leycom BV, the sole worldwide manufacturer of this invasive conductance-catheter-based system, which holds FDA 510(k) market clearance for clinical use in human patients. Due to the unique capabilities of CD Leycom’s system and its regulatory approval status, no other vendor can provide an equivalent product, justifying the non-competitive acquisition approach. This acquisition is conducted under FAR Part 12.603 for streamlined solicitation of commercial products and services and falls below the simplified acquisition threshold. It is issued as a Notice of Intent without plans for full and open competition, referencing authorities including FAR 6.302-3(a)(2)(ii) and 41 U.S.C. 1901. The applicable NAICS code is 334516, Analytical Laboratory Instrument Manufacturing, with a small business size standard of 1,000 employees; however, this requirement is not set aside for small businesses. The solicitation incorporates provisions effective as of March 13, 2026, per the latest Federal Acquisition Circular. The response deadline is set for June 23, 2026, with point of contact information provided for coordination.
National Institutes Of Health Olao

POSTED

1 day ago

DEADLINE

in 7 days
View Details
NAICS: 334516
New
Federal
Protective Clothing Blood Penetration Resistance TesterThe U.S. Food and Drug Administration’s Center for Devices and Radiological Health is conducting a market research effort to identify small businesses capable of supplying a Protective Clothing Blood Penetration Resistance Tester. This device is intended to automate and improve the testing of level 4 medical gowns for viral penetration resistance, significantly reducing manual testing time while enhancing consistency and repeatability. The instrument must meet several technical specifications, including the ability to run four simultaneous tests, automatic timing functions, real-time pressure monitoring, and compliance with ASTM F1670 and ASTM F1671 standards. The system must be new, turn-key, and include all necessary hardware, software, manuals, installation, training, and qualification documentation. Interested firms, particularly small businesses under NAICS code 334516, are invited to submit capability statements by June 23, 2026. Responses should include detailed company information, past performance data, technical compliance evidence, warranty terms, and manufacturing origin to facilitate evaluation under Buy American requirements. The delivery location is the FDA’s Winchester Engineering and Analytical Center in Massachusetts, with delivery expected within 120 days of award. This announcement does not constitute a solicitation or binding contract but serves as an information-gathering step for potential future procurements.
FDA Office Of Acq Grant Svcs

POSTED

1 day ago

DEADLINE

in 7 days
View Details
NAICS: 334516
New
Federal
NOI - Infors HT Multitron Incubation ShakerThe National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, has issued a combined synopsis/solicitation under the number 75N98026Q00639 for the procurement of an Infors HT Multitron Incubation Shaker, including integrated CO2 control, hygienic humidification, accessories, and installation. This purchase intends to extend a 15-year-old existing Multitron system used in the Laboratory of Structural Cell Biology at NHLBI. The solicitation is conducted as a non-competitive, sole-source action with Infors USA, the exclusive U.S. manufacturer and seller of this patented system, to ensure compatibility and integration with the existing equipment. The acquisition falls under the streamlined procedures outlined in FAR Subpart 12.6 and is not expected to exceed the simplified acquisition threshold. The solicitation is governed by Federal Acquisition Circular 2026-01, effective March 13, 2026, with the North American Industry Classification System (NAICS) code 334516 for Analytical Laboratory Instrument Manufacturing, and it is not set aside for small businesses. Proposals are requested promptly, with a response deadline of June 23, 2026. This action is authorized under FAR 12.603 and 41 U.S.C. 1901, reflecting the necessity of a direct award due to the unique integration requirements and the lack of comparable commercial items. The point of contact for this solicitation is Nicholas S. Capobianco at the NIH.
National Institutes Of Health Olao

POSTED

1 day ago

DEADLINE

in 7 days
View Details
NAICS: 334516
New
Federal
FDA-RFQ- BioProfile FLEX2 Parts and Components-Brand Name or EqualThe contract solicitation seeks quotations for supplying parts and components compatible with three Nova BioProfile FLEX 2 instruments owned by the FDA’s Center for Drug Evaluation and Research (CDER). The requirement includes parts for two main FLEX2 instruments and an additional external sampling module, each identified by specific serial numbers. The contractor must provide new, unused, and defect-free commercial parts or equivalent consumables that fully function with the instruments in their current configuration, without requiring modifications. Delivered items must maintain at least 75% to 80% of their shelf life, and those requiring special conditions such as refrigeration or flammable item handling must comply with relevant regulations. Only manufacturers or authorized resellers may submit quotes, which are due via email by June 26, 2026. The contract period covers 12 consecutive months from the award date, with performance based at the FDA facility in Silver Spring, Maryland. The procurement process is issued as a combined synopsis/solicitation under commercial item acquisition rules, with no separate solicitation document forthcoming. The solicitation emphasizes strict adherence to delivery schedules and quality standards detailed in the attached Statement of Work. Communication and submission of quotations are managed through the designated FDA point of contact.
FDA Office Of Acq Grant Svcs

POSTED

1 day ago

DEADLINE

in 10 days
View Details
NAICS: 334516
New
Federal
Laboratory reagentsThe contract pertains to the procurement of laboratory reagents for the Naval Medical Research Center under the Department of Defense. It is a solicitation issued on June 16, 2026, with a response deadline set for July 1, 2026, at 4:00 PM. The contract falls under the NAICS code 334516 and does not involve any set-aside programs. The contracting office is located in Silver Spring, Maryland. Interested parties are invited to submit their responses within the specified timeframe to support the procurement needs of laboratory reagents. The primary point of contact is Genaro Vasquez, who can be reached via email for any inquiries related to this solicitation. The contract details and additional information are accessible through the provided government website link.
Naval Medical Research Center

POSTED

1 day ago

DEADLINE

in 15 days
View Details